Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Increased Monocyte Chemoattractant Protein-1 in Knee Joints of Rats with Adjuvant-Induced Arthritis: In Vivo Microdialysis

SHAO-HSIANG LIU, CHIH-SHUNG WONG, and DEH-MING CHANG

ABSTRACT.

Objective. Imbalance of inflammatory and antiinflammatory cytokines plays a critical role in the pathogenesis of rheumatoid arthritis (RA). Precise determination of these cytokines would lead to better understanding of the progression of RA.

Methods. We developed an in vivo microdialysis technique to directly monitor cytokine profiles in knee joints of rats with adjuvant-induced arthritis (AIA). Microdialysates drained from knee joints of rats with AIA and controls were collected and cytokine concentrations were measured by ELISA. Pathological changes of the knee joints and the source of monocyte chemoattractant factor–1 (MCP-1) secretion were also determined by histology and immunohistochemistry.

Results. MCP-1 expression in knee joints was significantly higher in AIA rats with erosive changes in their ankles than in normal rats, while interleukin 6 (IL-6) levels were similar in both cases. IL-1ß and interferon-g were not detectable in the microdialysates. Increased synovial proliferation and mononuclear inflammatory infiltrates were observed. Synovial cells and mononuclear inflammatory cells expressed both MCP-1 and its receptor, CCR2.

Conclusion. Our results indicate that the in vivo microdialysis technique is capable of detecting cytokines in the knee joints of rats. Increased expression of MCP-1 and CCR2 in knee joints of AIA rats suggests a role for this cytokine in triggering the mechanisms involved in the pathogenesis of knee joint after ankle erosion. (J Rheumatol 2005;32:2205-11)

Key Indexing Terms:

RHEUMATOID ARTHRITIS
ADJUVANT-INDUCED ARTHRITIS
IN VIVO MICRODIALYSIS
MONOCYTE CHEMOATTRACTANT PROTEIN-1


From the Graduate Institute of Life Science; Department of Rheumatology/Immunology/Allergy; and Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

Supported by the National Science Council, Taiwan, Republic of China (NSC 91-2314-B-016-046).

S-H. Liu, MS, Graduate Institute of Life Science, Department of Rheumatology/Immunology/Allergy; C-S. Wong, MD, PhD, Department of Anesthesiology; D-M. Chang, MD, MS, FACR, Department of Rheumatology/Immunology/Allergy.

Address reprint requests to Dr. D-M. Chang, Rheumatology/Immunology/ Allergy, Tri-Service General Hospital, 325 Cheng-Kung Road, Section 2, Neihu 114, Taipei, Taiwan. E-mail: ming0503@ms3.hinet.net

Accepted for publication June 29, 2005.




Return to November 2005 Table of Contents



© 2005. The Journal of Rheumatology Publishing Company Limited.
All rights reserved.